2-methylene-19-nor-(20S)-1alpha-hydro xy-trishomopregnacalciferol

Details for Australian Patent Application No. 2005309819 (hide)

Owner Wisconsin Alumni Research Foundation

Inventors Deluca, Hector F.; Plum, Lori A.; Clagett-Dame, Margaret

Agent Spruson & Ferguson

Pub. Number AU-A-2005309819

PCT Pub. Number WO2006/057914

Priority 60/629,943 22.11.04 US

Filing date 18 November 2005

Wipo publication date 1 June 2006

International Classifications

C07C 401/00 (2006.01) Irradiation products of cholesterol or its derivatives

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/057914 Priority application(s): WO2006/057914

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309820-2-methylene-19,21-dinor-1alpha-hydrox y-bishomopregnacalciferol

2005309818-2-methylene-19-nor-(20R)-1-alpha-hydr oxy-bishomopregnacalciferol